Loeffler JS - Search Results

1

Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.

Lu-Emerson C, Duda DG, Emblem KE, Taylor JW, Gerstner ER, Loeffler JS, Batchelor TT, Jain RK. Lu-Emerson C, et al. Among authors: loeffler js. J Clin Oncol. 2015 Apr 1;33(10):1197-213. doi: 10.1200/JCO.2014.55.9575. Epub 2015 Feb 23. J Clin Oncol. 2015. PMID: 25713439 Free PMC article.

2

Radiosurgery as part of the initial management of patients with malignant gliomas.

Loeffler JS, Alexander E 3rd, Shea WM, Wen PY, Fine HA, Kooy HM, Black PM. Loeffler JS, et al. J Clin Oncol. 1992 Sep;10(9):1379-85. doi: 10.1200/JCO.1992.10.9.1379. J Clin Oncol. 1992. PMID: 1325539

3

Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.

Fine HA, Figg WD, Jaeckle K, Wen PY, Kyritsis AP, Loeffler JS, Levin VA, Black PM, Kaplan R, Pluda JM, Yung WK. Fine HA, et al. Among authors: loeffler js. J Clin Oncol. 2000 Feb;18(4):708-15. doi: 10.1200/JCO.2000.18.4.708. J Clin Oncol. 2000. PMID: 10673511 Clinical Trial.

4

Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.

Chakravarti A, Loeffler JS, Dyson NJ. Chakravarti A, et al. Among authors: loeffler js. Cancer Res. 2002 Jan 1;62(1):200-7. Cancer Res. 2002. PMID: 11782378

5

Quantitatively determined survivin expression levels are of prognostic value in human gliomas.

Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS. Chakravarti A, et al. Among authors: loeffler js. J Clin Oncol. 2002 Feb 15;20(4):1063-8. doi: 10.1200/JCO.2002.20.4.1063. J Clin Oncol. 2002. PMID: 11844831

6

Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.

Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS. Nguyen PL, et al. Among authors: loeffler js. J Clin Oncol. 2005 Mar 1;23(7):1507-13. doi: 10.1200/JCO.2005.01.161. J Clin Oncol. 2005. PMID: 15735126

7

Genetic analyses for predictors of radiation response in glioblastoma.

Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT. Shih HA, et al. Among authors: loeffler js. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):704-10. doi: 10.1016/j.ijrobp.2005.03.059. Epub 2005 Jun 22. Int J Radiat Oncol Biol Phys. 2005. PMID: 15978739

8

Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

Jain RK, Duda DG, Clark JW, Loeffler JS. Jain RK, et al. Among authors: loeffler js. Nat Clin Pract Oncol. 2006 Jan;3(1):24-40. doi: 10.1038/ncponc0403. Nat Clin Pract Oncol. 2006. PMID: 16407877 Review.

9

Primary CNS lymphoma.

Batchelor T, Loeffler JS. Batchelor T, et al. Among authors: loeffler js. J Clin Oncol. 2006 Mar 10;24(8):1281-8. doi: 10.1200/JCO.2005.04.8819. J Clin Oncol. 2006. PMID: 16525183 Review.

10

Impact of molecular profiling on clinical trial design for glioblastoma.

Chakravarti A, Tyndall E, Palanichamy K, Mehta M, Aldape K, Loeffler J. Chakravarti A, et al. Curr Oncol Rep. 2007 Jan;9(1):71-9. doi: 10.1007/BF02951429. Curr Oncol Rep. 2007. PMID: 17164051 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page